Subtype
Malignant Female Reproductive System Neoplasm
CI-CAN-00003157Explore in graph →
1,464 active trials11 approved drugs128 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003157Explore in graph →
Clinical trials
6,254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (740)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02244502 | Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE) | unknown | Phase 1 / Phase 2 | 31 | NovoCure Ltd.INDUSTRY | 4 | Sep 21, 2016 | clinicaltrials |
| NCT02560571 | Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients | unknown | Phase 2 | 200 | Meir Medical CenterOTHER | 1 | Sep 20, 2016 | clinicaltrials |
| NCT02888418 | Safety and Immunogenicity Study of Human Papilloma Virus Vaccine in Women Aged 9 to 30 and Men Aged 9 to 17 | unknown | Phase 1 | 135 | Beijing Chaoyang District Centre for Disease Control and PreventionOTHER | 0 | Sep 5, 2016 | clinicaltrials |
| NCT02884960 | Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization | unknown | N/A | 118 | Gary Siskin, MDOTHER | 0 | Sep 1, 2016 | clinicaltrials |
| NCT02875990 | Characterization of Immunosuppressive Signing of Cervical Cancer(Xac03) | unknown | N/A | 50 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 23, 2016 | clinicaltrials |
| NCT02457650 | T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies | unknown | Phase 1 | 36 | Shenzhen Second People's HospitalOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT02595021 | Total/Subtotal Colectomy in Ovarian Cancer | unknown | Phase 2 | 80 | Shanghai Gynecologic Oncology GroupOTHER_GOV | 1 | Jul 26, 2016 | clinicaltrials |
| NCT02835404 | Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer | unknown | Phase 2 | 200 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Jul 18, 2016 | clinicaltrials |
| NCT02545010 | Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer | unknown | Phase 1 | 24 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT02225015 | Cancer Prevention in Women With a BRCA Mutation | unknown | Phase 1 | 300 | Women's College HospitalOTHER | 1 | Jun 9, 2016 | clinicaltrials |
| NCT02503917 | Gynaecologic Organ Segmentation and Motion Tracking Using Ultrasound(GENIUS) | unknown | — | 25 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 23, 2016 | clinicaltrials |
| NCT01628757 | Model Development and Prospective Validation to Predict the Response to Neoadjuvant Chemotherapy in Cervical Cancer | unknown | — | 1,400 | Ding MaOTHER | 1 | May 17, 2016 | clinicaltrials |
| NCT02638402 | Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers | unknown | — | 250 | National Taiwan University HospitalOTHER | 0 | May 13, 2016 | clinicaltrials |
| NCT02762214 | Role of Uterine Manipulator in Hysterectomy - Ro.Man.HY(RoManHy) | unknown | Phase 3 | 154 | Catholic University of the Sacred HeartOTHER | 1 | May 4, 2016 | clinicaltrials |
| NCT01755845 | Trial of Postoperative Chemoradiotherapy With or Without Consolidation Chemotherapy for Cervical Cancer Patients | unknown | Phase 3 | 300 | xie congyingOTHER | 1 | Apr 28, 2016 | clinicaltrials |
| NCT01756170 | Postoperative Chemoradiation v.s Radiotherapy for Lymph Node Negative Cervical Cancer Patients | unknown | Phase 3 | 200 | xie congyingOTHER | 1 | Apr 28, 2016 | clinicaltrials |
| NCT02719041 | Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer: a Retrospective Study | unknown | — | 40 | Hillel Yaffe Medical CenterOTHER_GOV | 1 | Mar 25, 2016 | clinicaltrials |
| NCT02321735 | DOD Long-Term Survivors of Ovarian Cancer(LTSOC) | unknown | N/A | 400 | Massachusetts General HospitalOTHER | 1 | Mar 17, 2016 | clinicaltrials |
| NCT02703961 | Randomized Control Trial on Efficacy and Safety of Concurrent and Adjuvant Chemotherapy for the Cervical Cancer | unknown | Phase 3 | 598 | Air Force Military Medical University, ChinaOTHER | 1 | Mar 17, 2016 | clinicaltrials |
| NCT02711865 | Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer | unknown | — | 20 | Hillel Yaffe Medical CenterOTHER_GOV | 1 | Mar 17, 2016 | clinicaltrials |
| NCT02705612 | Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer | unknown | Phase 2 | 60 | Air Force Military Medical University, ChinaOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT02440750 | Endometrial Preparation Before Operative Hysteroscopy in Premenopausal Women | unknown | Phase 4 | 50 | University of CagliariOTHER | 0 | Mar 9, 2016 | clinicaltrials |
| NCT02686463 | Treatment for Malignant Ovarian Cancer: Laparoscopy vs Laparotomy | unknown | N/A | 150 | Shengjing HospitalOTHER | 0 | Feb 19, 2016 | clinicaltrials |
| NCT00660101 | Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer | unknown | Phase 1 / Phase 2 | 34 | AVAX TechnologiesINDUSTRY | 1 | Dec 3, 2015 | clinicaltrials |
| NCT02605941 | DNA Methylation Biomarkers for Cervical Cancer Screening | unknown | — | 5,000 | iStat Biomedical CO., Ltd.INDUSTRY | 1 | Nov 17, 2015 | clinicaltrials |
| NCT02580747 | Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso | unknown | Phase 1 | 20 | Chinese PLA General HospitalOTHER | 1 | Oct 20, 2015 | clinicaltrials |
| NCT00532194 | An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer(ICON6) | unknown | Phase 3 | 486 | Medical Research CouncilOTHER_GOV | 1 | Sep 23, 2015 | clinicaltrials |
| NCT02039791 | Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer | unknown | Phase 2 | 20 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Aug 19, 2015 | clinicaltrials |
| NCT02510027 | Triage Strategies in Cervical Cancer Prevention(FRIDA) | unknown | — | 100,000 | Instituto Nacional de Salud Publica, MexicoOTHER | 1 | Jul 28, 2015 | clinicaltrials |
| NCT02471027 | The Clinical Research of Neoadjuvant Chemotherapy Combined Surgery for Locally Advanced Cervical Cancer | unknown | — | 1,000 | Yu mei WuOTHER | 1 | Jun 12, 2015 | clinicaltrials |
| NCT02458001 | Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer(SAFFRON) | unknown | N/A | 100 | University College, LondonOTHER | 0 | May 29, 2015 | clinicaltrials |
| NCT01819077 | TMMR (Total Mesometrial Resection) Register Study(TMMR-RS) | unknown | — | 500 | University Hospital, EssenOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT02188550 | Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer | unknown | Phase 2 | 20 | Sinai Hospital of BaltimoreOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT02435186 | p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer | unknown | Phase 2 | 100 | Shenzhen SiBiono GeneTech Co.,LtdINDUSTRY | 1 | May 6, 2015 | clinicaltrials |
| NCT02422563 | NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Cervical Cancer FIGO Stage IB2 and IIB(NACOPRAD) | unknown | Phase 3 | 534 | Charite University, Berlin, GermanyOTHER | 0 | Apr 21, 2015 | clinicaltrials |
| NCT02406365 | Diagnostic Imaging Aid for Management of Cervical Lesions(FFC) | unknown | Phase 2 | 618 | Brookdale University Hospital Medical CenterOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT02406391 | Adherence to Preventive Care for Cervical Cancer(Adh-NYC-EP) | unknown | — | 400 | Brookdale University Hospital Medical CenterOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT02368574 | Comparison of Class II and Class III Hysterectomy in Early Stage Cervical Cancer Cervical Cancer | unknown | N/A | 500 | Chinese Gynecological Oncology GroupOTHER_GOV | 0 | Feb 23, 2015 | clinicaltrials |
| NCT02367950 | Exercise as an Intervention in Endometrial Cancer Survivors | unknown | N/A | 50 | Royal Cornwall Hospitals TrustOTHER | 1 | Feb 20, 2015 | clinicaltrials |
| NCT02368067 | Improved Method of Detecting Cancer Metastases(SITs) | unknown | N/A | 30 | Southeastern Regional Medical CenterOTHER | 1 | Feb 20, 2015 | clinicaltrials |
| NCT01974193 | Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gynecologic Cancer | unknown | Phase 3 | 40 | Ewha Womans University Mokdong HospitalOTHER | 1 | Feb 11, 2015 | clinicaltrials |
| NCT01635452 | A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids(PREMYA) | unknown | — | 1,500 | PregLem SAINDUSTRY | 10 | Jan 27, 2015 | clinicaltrials |
| NCT01715168 | A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer | unknown | Phase 1 | 40 | Azaya Therapeutics, Inc.INDUSTRY | 2 | Jan 15, 2015 | clinicaltrials |
| NCT02323841 | Feasibility Study: Conservative Treatment in Cervical Cancer | unknown | Early Phase 1 | 30 | Catholic University of the Sacred HeartOTHER | 1 | Dec 24, 2014 | clinicaltrials |
| NCT01187602 | Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer(sncRNA) | unknown | — | 103 | University of VirginiaOTHER | 1 | Dec 5, 2014 | clinicaltrials |
| NCT02283502 | Clinical Test of the MRgHIFU System on Uterine Fibroids(MRgHIFU) | unknown | Phase 1 | 20 | Chin-Jung WangOTHER | 1 | Nov 5, 2014 | clinicaltrials |
| NCT01307774 | Survey of Predictors of Human Papillomavirus (HPV) Vaccination Among Parents of Rural Adolescent Girls in Mysore, India | unknown | — | 800 | Purnima MadhivananOTHER | 1 | Oct 29, 2014 | clinicaltrials |
| NCT00410462 | Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma | unknown | Phase 2 | 118 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Aug 8, 2014 | clinicaltrials |
| NCT00004206 | Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer | unknown | Phase 2 | — | University of LeicesterOTHER | 1 | Jun 24, 2014 | clinicaltrials |
| NCT02132988 | Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer | unknown | Phase 2 | 110 | Mackay Memorial HospitalOTHER | 1 | May 7, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Sep 21, 2016source: clinicaltrials